Organogenesis Holdings Inc. (ORGO) › Operating IncomeOrganogenesis Holdings Inc. (ORGO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$8.78M2017: -$5.49M2018: -$51.56M2019: -$29.85M2020: $26.70M2021: $72.22M2022: $22.30M2023: $12.53M2024: -$1.28M2025: $44.69M$44.69M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$44.69M+3583.6%2024-$1.28M-110.2%2023$12.53M-43.8%2022$22.30M-69.1%2021$72.22M+170.5%2020$26.70M+189.4%2019-$29.85M+42.1%2018-$51.56M-838.4%2017-$5.49M+37.4%2016-$8.78M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share